Chemistry Reference
In-Depth Information
19. Soldatos G, Cooper ME, and Jandeleit-Dahm KA. Advanced-glycation end products in
insulin-resistant states.
Curr Hypertens Rep
2005;7:96-102.
20. Unno Y, Sakai M, and Sakamoto Y et al. Advanced glycation end products-modified
proteins and oxidized LDL mediate down-regulation of leptin in mouse adipocytes via
CD36.
Biochem Biophys Res Commun
2004;325:151-156.
21. Bohlender JM, Franke S, Stein G, and Wolf G. Advanced glycation end products and the
kidney.
Am J Physiol Renal Physiol
2005;289:F645-659.
22. Sunahori K, Yamamura M, and Yamana J et al. Increased expression of receptor for
advanced glycation end products by synovial tissue macrophages in rheumatoid arthri-
tis.
Arthritis Rheum
2006;54:97-104.
23. de Leeuw K, Kallenberg C, and Bijl M. Accelerated atherosclerosis in patients with
systemic autoimmune diseases.
Ann N Y Acad Sci
2005;1051:362-371.
24. Ge J, Jia Q, and Liang C et al. Advanced glycosylation end products might promote
atherosclerosis through inducing the immune maturation of dendritic cells.
Arterioscler
Thromb Vasc Biol
2005;25:2157-2163.
25. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myo-
cardial stiffening of aging and diabetes.
J Hypertension
2003;21:3-12.
26. Monnier VM, Sell DR, and Genuth S. Glycation products as markers and predictors of
the progression of diabetic complications.
Ann N Y Acad Sci
2005;1043:567-581.
27. Bierhaus A, Humpert PM, and Morcos M, Understanding RAGE, the receptor for
advanced glycation end products.
J Mol Med
2005;83:876-886.
28. Brandtzaeg P, Halstensen TS, and Krajci P et al. Immunobiology and immunopa-
thology of human gut mucosa: Humoral immunity and intraepithelial lymphocytes.
Gastroenterology
1989;97:1562-1584.
29. Zittermann A, Schleithoff SS, and Koerfer R. Putting cardiovascular disease and vitamin
D insufficiency into perspective.
Br J Nutr
2005;94:483-492.
30. McCarty MF. Secondary hyperparathyroidism promotes the acute phase response—A
rational for supplementing vitamin D in prevention of vascular events in elderly.
Med
Hypotheses
2005;64:1022-1026.
31. Mattsson MP. Will caloric restriction and folate protect against AD and PD?
Neurology
2003;60:690-695.
32. Hertoghe T. The “multiple hormone deficiency” theory of aging: Is human senes-
cence caused mainly by multiple hormone deficiencies?
Ann NY Acad Sci
2005;1057:448-465.
33. Yamagishi S, Fujimori H, and Yonekura H et al. Advanced glycation end products inhibit
prostacyclin production and induce plasminogen activator inhibitor-1 in human micro-
vascular endothelial cells.
Diabetologica
1998;41:1435-1441.
34. Suzuma K, Otani A, and Oh H et al. 17-beta-Estradiol increases VEGF receptor-2 and
promotes DNA synthesis in retinal microvascular endothelial cells.
Invest Ophthalmol
Vis Sci
1999;40:2122-2129.
35. Cooper EV. Gas gangrene following injection of adrenaline.
Lancet
1946;247:459-461.
36. Kinney KS, Austin CE, and Morton DS, Sonnenfeld G. Norepinephrine as a growth
stimulating factor in bacteria—Mechanistic studies.
Life Sci
2000;67:3075-3085.
37. Alverdy JC, Laughlin RS, and Wu L. Influence of the critically ill state on host-patho-
gen interactions within the intestine: Gut-derived sepsis redefined.
Crit Care Med
2003;31:598-607.
38. Peskind ER
,
Elrod R, and Dobie DJ et al. Cerebrospinal fluid epinephrine in Alzheimer's
disease and normal aging
.
Neurophycopharmacology
1998;19:465-471.
